Justice Jackson Was Partly Mistaken About Mifepristone

Key Takeaways

• Supreme Court emergency docket surged amid executive‑order disputes
• Jackson argued court created new policy under Trump, partially inaccurate
• Biden’s 2021 mifepristone policy fell within statute of limitations
• District courts often stay rulings against Biden, unlike Trump cases
• Kavanaugh defends court’s role in checking executive overreach

Summary

At a recent D.C. Circuit event, Justices Kavanaugh and Jackson debated the Supreme Court’s expanding emergency docket. Kavanaugh linked the surge to increased presidential reliance on executive orders, while Jackson claimed the Court’s emergency orders under Trump represented a shift toward new policy-making. The article counters Jackson’s point, noting that the 2021 Biden policy on the abortion drug mifepristone was a legitimate, timely action within statutory limits, not a novel policy change. It also highlights the asymmetry in judicial stays between Biden and Trump administrations.

Pulse Analysis

The Supreme Court’s emergency docket has become a flashpoint in the broader battle over executive power. As Congress stalls, presidents turn to executive orders, prompting litigants to seek rapid judicial relief. Justices Kavanaugh and Jackson epitomize the ideological divide: Kavanaugh views the surge as a natural consequence of legislative gridlock, while Jackson worries the Court is venturing beyond its traditional role of preserving the status quo. This tension reflects a judiciary increasingly called upon to adjudicate policy disputes before lower courts have fully weighed the issues.

The mifepristone controversy illustrates the practical stakes of emergency rulings. In 2021, the FDA relaxed in‑person visit requirements for the abortion pill, a change grounded in pandemic‑era experience and well within the statute of limitations. Critics, including Justice Jackson, framed the Supreme Court’s emergency stay as an overreach, suggesting it created new policy rather than merely maintaining existing law. However, the legal record shows the action was a timely response to an existing regulatory framework, not a novel policy shift, challenging the narrative of judicial activism.

Beyond the specific drug case, the pattern of judicial behavior reveals a partisan asymmetry. District judges frequently stay adverse rulings against the Biden administration, whereas similar challenges to Trump‑era policies have faced fewer procedural cushions, prompting more frequent emergency appeals to the high court. This disparity raises questions about consistency in judicial restraint and the long‑term credibility of the Court’s emergency docket. As the judiciary continues to navigate these high‑stakes disputes, its approach will shape the balance of power among the branches and signal how future administrations might anticipate—or avoid—court‑driven policy interventions.